WHO. Child mortality and causes of death. 2023. Available from: https://www.who.int/data/gho/data/themes/topics/topic-details/GHO/child-mortality-and-causes-of-death. Accessed 30 Oct 2023.

França EB, Lansky S, Rego MAS, Malta DC, França JS, Teixeira R, et al. Principais causas da mortalidade na infância no Brasil, em 1990 e 2015: estimativas do estudo de Carga Global de Doença. Rev Bras Epidemiol. 2017;20:46–60.

Article  Google Scholar 

Divecha C, Tullu MS, Chaudhary S. Burden of respiratory illnesses in pediatric intensive care unit and predictors of mortality: experience from a low resource country. Pediatr Pulmonol. 2019;54:1234–41.

Article  PubMed  Google Scholar 

Attard TM, Miller M, Pant C, Kumar A, Thomson M. Mortality associated with gastrointestinal bleeding in children: a retrospective cohort study. World J Gastroenterol. 2017;23:1608.

Article  PubMed  PubMed Central  Google Scholar 

Kyu HH, Stein CE, Boschi Pinto C, Rakovac I, Weber MW, Dannemann Purnat T, et al. Causes of death among children aged 5–14 years in the WHO European Region: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Child Adolesc Heal. 2018;2:321–37.

Article  Google Scholar 

Lam JKW, Xu Y, Worsley A, Wong ICK. Oral transmucosal drug delivery for pediatric use. Adv Drug Deliv Rev. 2014;73:50–62.

Article  CAS  PubMed  Google Scholar 

Yellepeddi VK, Joseph A, Nance E. Pharmacokinetics of nanotechnology-based formulations in pediatric populations. Adv Drug Deliv Rev. 2019;151–152:44–55.

Article  PubMed  PubMed Central  Google Scholar 

Nir-Neuman H, Abu-Kishk I, Toledano M, Heyman E, Ziv-Baran T, Berkovitch M. Unlicensed and off-label medication use in pediatric and neonatal intensive care units: no change over a decade. Adv Ther. 2018;35:1122–32.

Article  PubMed  Google Scholar 

Ivanovska V, Rademaker CMA, Van Dijk L, Mantel-Teeuwisse AK. Pediatric drug formulations: review of challenges and progress. Pediatrics. 2014;134:361–72.

Article  PubMed  Google Scholar 

Allen HC, Garbe MC, Lees J, Aziz N, Chaaban H, Miller JL, et al. Off-label medication use in children, more common than we think: a systematic review of the literature. J Okla State Med Assoc. 2018;111:776.

PubMed  PubMed Central  Google Scholar 

Kasahun AE, Sendekie AK. Are pediatrics taking the prescribed tablet dosage form? Practices of off-label tablet modification in pediatric wards: a prospective observational study. Heliyon. 2023;9:e15109.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rautamo M, Kvarnström K, Sivén M, Airaksinen M, Lahdenne P, Sandler N. A focus group study about oral drug administration practices at hospital wards—aspects to consider in drug development of age-appropriate formulations for children. Pharmaceutics. 2020;12:1–13.

Article  Google Scholar 

van der Zanden TM, Smeets NJL, de Hoop-Sommen M, Schwerzel MFT, Huang HJ, Barten LJC, et al. Off-label, but on-evidence? a review of the level of evidence for pediatric pharmacotherapy. Clin Pharmacol Ther. 2022;112:1243–53.

Article  PubMed  PubMed Central  Google Scholar 

Galande AD, Khurana NA, Mutalik S. Pediatric dosage forms - challenges and recent developments: a critical review. J Appl Pharm Sci. 2020;10:155–66.

Article  CAS  Google Scholar 

Marques MS, Lima LA, Poletto F, Contri RV, Kulkamp Guerreiro IC. Nanotechnology for the treatment of paediatric diseases: a review. J Drug Deliv Sci Technol. 2022;75: 103628.

Article  CAS  Google Scholar 

Guidi B, Parziale A, Nocco L, Maiese A, La Russa R, Di Paolo M, et al. Regulating pediatric off-label uses of medicines in the EU and USA: challenges and potential solutions: Comparative regulation framework of off label prescriptions in pediatrics: a review. Int J Clin Pharm. 2022;44:264–9.

Article  PubMed  Google Scholar 

Spadoni C. Pediatric drug development: challenges and opportunities. Curr Ther Res. 2019;90:119–22.

Article  PubMed  Google Scholar 

Asfour MH, Abd El-Alim SH, Kassem AA, Salama A, Gouda AS, Nazim WS, et al. Vitamin D3-loaded nanoemulsions as a potential drug delivery system for autistic children: formulation development, safety, and pharmacokinetic studies. AAPS PharmSciTech. 2023;24:58.

Article  CAS  PubMed  Google Scholar 

Been S, Choi J, Lee YH, Kim PY, Kim WK, Cho HH, et al. Improvement of medication adherence and controlled drug release by optimized acetaminophen formulation. Macromol Res. 2021;29:342–50.

Article  CAS  Google Scholar 

Kean EA, Adeleke OA. Orally disintegrating drug carriers for paediatric pharmacotherapy. Eur J Pharm Sci. 2023;182:106377.

Article  CAS  PubMed  Google Scholar 

Yoo O, Tang EKY, Salman S, Nguyen MN, Sommerfield D, Sommerfield A, et al. A randomised controlled trial of a novel tramadol chewable tablet: pharmacokinetics and tolerability in children. Anaesthesia. 2022;77:438–48.

Article  CAS  PubMed  Google Scholar 

Laquintana V, Asim MH, Lopedota A, Cutrignelli A, Lopalco A, Franco M, et al. Thiolated hydroxypropyl-β-cyclodextrin as mucoadhesive excipient for oral delivery of budesonide in liquid paediatric formulation. Int J Pharm. 2019;572:118820.

Article  CAS  PubMed  Google Scholar 

Cirri M, Maestrini L, Maestrelli F, Mennini N, Mura P, Ghelardini C, et al. Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy. Drug Deliv. 2018;25:1910–21.

Article  CAS  PubMed  PubMed Central  Google Scholar 

FDA. Reviews of pediatric studies conducted under BPCA and PREA from 2012–present. 2023. Available: https://www.fda.gov/drugs/development-resources/reviews-pediatric-studies-conducted-under-bpca-and-prea-2012-present. Accessed 30 Oct 2023.

The Business Research Company. Theranostics Market Size, Trends, Growth | 2024 to 2033. 2024. Available: https://www.thebusinessresearchcompany.com/report/theranostics-global-market-report. Accessed 8 July 2024.

May M. Eight ways machine learning is assisting medicine. Nat Med. 2021;27:2–3.

Article  CAS  PubMed  Google Scholar 

Matsushita FY, Krebs VLJ, de Carvalho WB. Artificial intelligence and machine learning in pediatrics and neonatology healthcare. Rev Assoc Med Bras. 2022;68:745–50.

Article  PubMed  PubMed Central  Google Scholar 

Cui J, Zhao L, Liu X, Liu M, Zhong L. Analysis of the potential inappropriate use of medications in pediatric outpatients in China. BMC Health Serv Res. 2021;21:1–12.

Article  Google Scholar 

Houweling LMA, Bezemer ID, Penning-Van Beest FJA, Meijer WM, Van Lingen RA, Herings RMC. First year of life medication use and hospital admission rates: premature compared with term infants. J Pediatr. 2013;163:61-6.e1.

Article  PubMed  Google Scholar 

Schmiedl S, Fischer R, Ibanez L, Fortuny J, Klungel OH, Reynolds R, et al. Utilisation and off-label prescriptions of respiratory drugs in children. PLoS ONE. 2014;9:e105110.

Article  PubMed  PubMed Central  Google Scholar 

Conroy S, McIntyre J, Choonara I. Unlicensed and off label drug use in neonates. Arch Dis Child Fetal Neonatal Ed. 1999;80:142–5.

Article  Google Scholar 

Jong GW, Eland IA, Sturkenboom MCJM, van den Anker JN, Stricker BHC. Unlicensed and off-label prescription of respiratory drugs to children. Euro Respir J. 2004;23:310–3.

Article  Google Scholar 

Shah SS, Hall M, Goodman DM, Feuer P, Sharma V, Fargason C, et al. Off-label drug use in hospitalized children. Arch Pediatr Adolesc Med. 2007;161:282–90.

Article  PubMed  Google Scholar 

Yackey K, Stukus K, Cohen D, Kline D, Zhao S, Stanley R. Off-label medication prescribing patterns in pediatrics: an update. Hosp Pediatr. 2019;9:186–93.

Article  PubMed  Google Scholar 

Kuch BA, Saville AL, De Toledo JS, Venkataraman ST. Inhaled pulmonary vasodilators: are there indications within the pediatric ICU? Respir Care. 2017;62:678–98.

Article  PubMed  Google Scholar 

Agency EM. ANNUAL REPORT 2022. 2022. Available: https://www.ema.europa.eu/en/annual-report/2022/index.html Accessed 8 July 2024.